Why catalytic investments funding is crucial to preventing HIV among people who use drugs |

Publisher: HRI & Frontline AIDS

“Harm reduction interventions for people who use drugs—such as needle and syringe programmes (NSP) and opioid
substitution therapy (OST)—are cost-effective, protect against HIV and hepatitis C, and save lives. Harm reduction is explicitly
mentioned in one of the five combination prevention pillars endorsed by the Global HIV Prevention Coalition”